The Regulator

Three: that is how many federal vaccine-recommendation categories the Department of Health and Human Services is now asking the public to help rewrite, a review whose outcome could determine which shots insurers must cover at zero cost to patients. The Department of Health and Human Services (HHS) posted a Request for Information August 21, 2026 (Docket No. HHS-OS-2026-0332, scheduled for official Federal Register publication August 24) asking whether the three categories currently used in federal vaccine guidance, Routine/Universal, Risk-Based, and Shared Clinical Decision-Making, are still adequate. The RFI implements the Task Force on Safer Childhood Vaccines and an August 10, 2026 executive order, “Delivering Gold Standard Childhood Vaccine Recommendations for Americans.” The distinction carries real dollar stakes: under the Affordable Care Act, private insurers must cover Advisory Committee on Immunization Practices-recommended vaccines with no patient cost-sharing only when they carry the “Routine” designation, so any recategorization coming out of this review could change which vaccines families get for free versus pay for out of pocket. Comments are due September 20, 2026. Confidence: High on the RFI’s existence, scope, and deadline, reviewed directly via the Federal Register. Medium on the downstream coverage-mandate implication, which is this newsletter’s analysis of the stakes, not a stated HHS position. Sources: Request for Information: Categories Used in Federal Vaccine Recommendations and the Role of Shared Clinical Decision-Making, Federal Register.

23.7 cents: that is the property tax rate per $100 of value an El Paso, Texas hospital district wants to hold flat tomorrow, even as its own CEO warns uninsured patient care could climb toward $277 million next year. The University Medical Center of El Paso Board of Managers and the El Paso County Commissioners Court voted this week to introduce a “no-new-revenue” tax rate of 23.7 cents per $100 of assessed value, down numerically from 24 cents, for the El Paso County Hospital District, which operates University Medical Center of El Paso and El Paso Children’s Hospital. Because home values are rising, the rate still pushes the average $240,000 home’s hospital-district tax bill to about $568 a year, roughly $10 more than last year; commissioners are scheduled to formally adopt the rate and the district’s fiscal year 2027 budget Monday, August 24, without a public hearing, since a no-new-revenue rate does not require one. Hospital district president and CEO Jacob Cintron told local reporters UMC projects uninsured patient care will cost the system roughly $277 million in the coming fiscal year and warned, “There may be a time that, if the uninsured amount increases, we may have to come back for a tax increase.” Confidence: Medium-High. This run reviewed direct local reporting on the commissioners’ vote and the CEO’s on-record statement; the county’s own rate notice is a scanned PDF this run could not machine-read. Sources: El Paso County hospital district proposes lower tax rate; many homeowners may pay more, KFOX14.

August 24: that is the deadline, tomorrow, for drugmakers to tell federal regulators whether they want to flip how they pay 340B safety-net hospitals and clinics from an upfront discount to a rebate. The Health Resources and Services Administration (HRSA), whose revived 340B Rebate Model Pilot Program this newsletter first covered August 6, published the formal notice August 3, 2026 in the Federal Register giving manufacturers of drugs selected for the Medicare Drug Price Negotiation Program’s 2026 and 2027 initial price applicability years until tomorrow to submit participation plans. Manufacturers HRSA approves by September 24 can switch, starting January 1, 2027, to rebating 340B covered entities after the sale instead of discounting them upfront at the point of sale, and must give covered entities 90 days’ notice before the switch takes effect; hospital groups have warned the change could strain safety-net providers’ cash flow by forcing them to front full price and wait for reimbursement. Confidence: Medium. This run reviewed HRSA’s and the Federal Register’s own program materials through secondary trade and legal-press corroboration, since HRSA’s and the Federal Register’s pages returned access errors on direct fetch. Sources: Notice Regarding 340B Rebate Model Pilot Program, Federal Register.

$12 million and an armed home invasion: that is the scale, and the violence, federal prosecutors say four Bronx men used to run a fake-ride Medicaid scheme for years without getting caught. The U.S. Attorney’s Office for the Southern District of New York unsealed a nine-count indictment August 20, 2026 against Louis Trejo, 43 (“Machete”), Kenneth Garner, 48 (“KG”), Harold Stevenson, 59 (“Bazz”), and Erihk Belis, 50 (“Eddie”), all of the Bronx, alleging they ran a racketeering enterprise that logged fake non-emergency medical transportation rides to and from methadone clinics using GPS-spoofing technology to fake proof of service, paid patients recurring kickbacks in cash and drugs to keep their Medicaid numbers in the scheme, and laundered roughly $12 million in proceeds partly through a sham charity called Forward Foundation. Prosecutors also allege the group carried out an armed home invasion robbery against the leader of a rival Medicaid fraud ring, adding Racketeer Influenced and Corrupt Organizations Act, Anti-Kickback Statute, firearms, and narcotics charges on top of the health care fraud counts. Confidence: High. This newsletter’s fraud-monitoring scan reviewed the Department of Justice’s own press release directly this week. Sources: Four Members of “War Room” Charged in Connection with $12M Medicaid Fraud Scheme, U.S. Department of Justice.

Two years: that is the prison sentence a Massachusetts telemedicine company owner got this week for running a $110 million scheme built on doctors who never spoke to their patients. Steven Richardson, former owner of Expansion Media and Hybrid Management Group, was sentenced in the U.S. District Court for the District of Massachusetts to two years in prison for conspiracy to commit health care fraud, capping a scheme prosecutors say ran from March 2016 to January 2023: Richardson’s companies paid telemarketing firms on a per-order basis to generate leads targeting Medicare beneficiaries for durable medical equipment such as back and knee braces, then used medical staffing companies to find doctors and nurses willing to sign prepopulated orders, typically without ever examining or even speaking to the patient, falsely documenting the orders as legitimate exams. Richardson pleaded guilty in April 2024 and agreed that $15,721,854.75 in proceeds is subject to forfeiture; the case is a real-world example of the exact fraud pattern, a supplier, a physician order, and a beneficiary ID, that the HHS Office of Inspector General warned last week keeps outrunning Medicare’s safeguards. Confidence: High on the scheme mechanics and forfeiture figure, drawn from the Department of Justice’s own case filings and reporting. Medium on the exact sentencing date, since the U.S. Attorney’s Office press release could not be independently retrieved this run. Sources: Former Owner of Telemedicine Companies Sentenced to Two Years in Prison for $110 Million Medicare Fraud Scheme, U.S. Attorney’s Office, District of Massachusetts.

165,000: that is roughly how many units of a stroke-prevention device the FDA has now given its most serious recall classification, after the device’s own protective tip started breaking off inside patients’ arteries. The Food and Drug Administration (FDA) confirmed a Class I recall, its highest risk category, for Boston Scientific’s Enroute Transcarotid Neuroprotection System (more than 115,000 units) and Enroute Transcarotid Neuroprotection System Plus (nearly 50,000 units), devices vascular surgeons use during transcarotid artery revascularization to catch debris and prevent stroke while treating carotid artery disease. The problem is a risk that the device’s own arterial sheath tip separates or partially separates during the procedure, which can require surgery to retrieve the fragment and can itself cause the stroke, transient ischemic attack, or blood clot the device is meant to prevent; FDA first flagged the issue in a July 27, 2026 early alert, when Boston Scientific had reported one serious injury. Confidence: Medium. This run reviewed FDA’s July 27 early alert directly; the exact date of the subsequent Class I classification could not be confirmed on FDA’s own recall database, which returned access errors this run, so the classification date and final unit counts are drawn from trade press review of that database. Sources: Early Alert: Percutaneous Catheter Issue from Boston Scientific, U.S. Food and Drug Administration, FDA confirms Class I recall for thousands of stroke prevention devices, Cardiovascular Business.